Lee's Pharmaceutical
Ivan Lee serves as the Director of Sales and Marketing at Lee's Pharmaceutical Holdings Limited, leading business development for the Greater Bay Area and Southeast Asia since September 2020. Previously, Ivan held various roles at Roche from 2016 to 2020, including Strategic Partner and Sales Manager, where responsibilities included developing partnering strategies, managing sales teams, and launching innovative products. With prior experience at AstraZeneca, Pfizer, and Le Crème, Ivan has demonstrated expertise in sales strategy formulation, business development, and market launches across the pharmaceutical and healthcare sectors. Ivan holds an MBA from The Hong Kong Polytechnic University and a Bachelor's degree in Biology from The Hong Kong University of Science and Technology.
This person is not in any teams
This person is not in any offices
Lee's Pharmaceutical
Lee's Pharmaceutical Holdings Limited is a Hong Kong-based investment holding company principally engaged in the development, manufacture, marketing and sales of pharmaceutical products. The Company operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutical products. Its proprietary products include Yallaferon, Livaracine and Slounase, among others. Licensed-in Products segment is engaged in the trading of licensed-in pharmaceutical products. Its licensed-in products include Ferplex and Zanidip, among others. The Company's products are for cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology, among others. The Company mainly operates businesses in China and Hong Kong.